ArticleBMJ open2022

Oral glucose tolerance testing as a complement to fasting plasma glucose in screening for type 2 diabetes: population-based cross-sectional analyses of 146 000 health examinations in Västerbotten, Sweden.

Anna Rosén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.